Piper Sandler lowered the firm’s price target on Dentsply Sirona to $32 from $35 and keeps a Neutral rating on the shares following the Q1 report. The sales miss can be traced to a handful of factors, most of which are macro-related, but these items and currency are contributing to management now pointing to the lower-end of its organic growth and earnings guidance ranges, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Dentsply Sirona still sees FY24 adjusted EPS $2.00-$2.10, consensus $2.06
- Dentsply Sirona reports Q1 adjusted EPS 42c, consensus 42c
- XRAY Upcoming Earnings Report: What to Expect?
- Dentsply Sirona to Host First Quarter Conference Call on May 2nd
- Dentsply Sirona to replace Fox Factory in S&P 400 at open on 4/3